Trial Profile
A Proof of Concept Study to Assess the Safety and IOP-Lowering Effect of AL-59412C Injected Intravitreally
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs AL 59412C (Primary) ; Travoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Proof of concept; Therapeutic Use
- Sponsors Alcon
- 27 Oct 2015 New trial record